Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Acquired slow-channel syndrome.

R H Scola1, L C Werneck, F M Iwamoto

  • 1Neuromuscular Disorders Division, Hospital de Clinicas of Federal University of Parana, 181 General Carneiro Street, Curitiba 80.069-900, Brazil.

Muscle & Nerve
|September 26, 2000
PubMed
Summary

This study highlights a patient with hereditary slow-channel syndrome (SCS) and acetylcholine receptor antibodies (AChR-Abs). Early detection of AChR-Abs is crucial for effective treatment of SCS.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Semiautomated volumetric measurement on postcontrast MR imaging for analysis of recurrent and residual disease in glioblastoma multiforme.

AJNR. American journal of neuroradiology·2013
Same author

Coexistence of primary sclerosing cholangitis in a patient with myasthenia gravis.

Annals of Indian Academy of Neurology·2012
Same author

Detection of spinal muscular atrophy carriers in a sample of the Brazilian population.

Neuroepidemiology·2011
Same author

Neuromuscular junction toxicity with tandutinib induces a myasthenic-like syndrome.

Neurology·2011
Same author

Symptom onset of spinocerebellar ataxia type 10 in pregnancy and puerperium.

Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia·2011
Same author

Molecular characterisation of congenital myasthenic syndromes in Southern Brazil.

Journal of neurology, neurosurgery, and psychiatry·2010

Area of Science:

  • Neurology
  • Clinical Electrophysiology
  • Immunology

Background:

  • Hereditary slow-channel syndrome (SCS) is a rare neuromuscular disorder affecting muscle excitability.
  • Acetylcholine receptor antibodies (AChR-Abs) are typically associated with myasthenia gravis.
  • Co-occurrence of SCS and AChR-Abs presents diagnostic and therapeutic challenges.

Observation:

  • A 37-year-old male presented with progressive muscle weakness in shoulder and hand muscles.
  • Electrophysiological studies revealed characteristic features of SCS, including double compound muscle action potentials (CMAPs) and significant CMAP decrement (>10%) upon repetitive nerve stimulation.
  • The patient was found to have elevated AChR-Abs.

Findings:

  • The patient demonstrated a positive clinical response to pyridostigmine, a treatment commonly used for myasthenia gravis.

Related Experiment Videos

  • The presence of AChR-Abs in a patient with hereditary SCS suggests a potential autoimmune component or overlap syndrome.
  • This case underscores the importance of assessing AChR-Ab titers in individuals suspected of having hereditary SCS.

    • Implications:

    • Identifying AChR-Abs in SCS patients may predict a favorable response to treatments like pyridostigmine.
    • This finding broadens the understanding of the pathophysiology and treatment spectrum for SCS.
    • Further research is warranted to elucidate the mechanisms underlying the co-occurrence of SCS and AChR-Abs and their therapeutic implications.